Home Tags Cannabis

Tag: cannabis

Curaleaf Opens 27th Dispensary in Florida

Jensen Beach, FL—Curaleaf Holdings opened its 27th dispensary in Florida on Friday, November 15, according to a press release, as part of its strategy...

FDA, FTC Post Warning Letter to Rooted Apothecary Over CBD Products, Claims

Silver Spring, MD—FDA and FTC posted a joint warning letter to Rooted Apothecary LLC for illegally selling unapproved products containing cannabidiol (CBD) online with...

Neptune Begins Production of Cannabis and Hemp Extracts

Laval, QC, Canada—Neptune Wellness Solutions is moving forward with its hemp extract business—in one press release, it announced that its Sherbrooke, Quebec facility is...

NCIA Asks Congress to Legalize Cannabis, Improve Public Safety

Washington, D.C.—The National Cannabis Industry Association (NCIA) delivered a letter to both chambers of Congress urging sensible and timely federal action in response to...

The Latest in Independent Testing: Part 2

Continuing our talk with Elan M. Sudberg, CEO, Alkemist Labs, and Jesse Miller, Ph.D., Director, NSF International Applied Research Center, we take a closer...

“The Father of Cannabis Research” to be Honored

San Fransisco, CA-- “The Father of Cannabis Research" Raphael Mechoulam will be honored with a Lifetime Achievement Award and a $10,000 research grant from The...

FTC Warns More CBD Companies Over Health Claims

Washington, D.C.--The Federal Trade Commission announced that, as part of its regular monitoring of health-related advertising claims, it sent warning letters to three companies...

Hemp Crops in Hawaii Destroyed

Hawaii—More than half the hemp crops cultivated in Hawaii this past year had to be destroyed due to high THC levels, according to Hawaii...

Big Pharma, the Opioid Crisis, and Natural Pain Relief

Oklahoma—Judge Thad Balkman of Cleveland County District Court ruled on Monday that Johnson & Johnson (J&J) had intentionally downplayed the risks and oversold the...

Industry Reacts to Gottlieb’s Op-Ed: Agree With His Urgency, Disagree With His Methods

Washington, D.C.—Scott Gottlieb, M.D., resident fellow at the American Enterprise Institute and former commissioner of FDA, wrote an op-ed in The Washington Post calling...

BACK ISSUES